Adolescent Pregnancy and Contraception

Primary Care - Clinics in Office Practice

Volumn 41, Issue 3, 2014, Pages 607-629

  Dalby, Jessica ^a   Hayon, Ronni ^a   Carlson, Jensena ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adolescent; Confidentiality; Contraception; LARC; Pregnancy

Indexed keywords

COPPER INTRAUTERINE DEVICE; ESTROGEN; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; ULIPRISTAL;

ABDOMINAL CRAMP; ACNE; ADOLESCENT; ADOLESCENT PREGNANCY; ADOLESCENT SEXUAL BEHAVIOR; BODY WEIGHT DISORDER; BONE DENSITY; BREAST DISEASE; CONDOM USE; CONFIDENTIALITY; CONTRACEPTION; COUNSELING; DYSMENORRHEA; EMERGENCY CONTRACEPTION; HEADACHE; HEALTH CARE ACCESS; HEALTH PROMOTION; HELP SEEKING BEHAVIOR; HORMONAL CONTRACEPTION; HUMAN; INFORMED CONSENT; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; MENSTRUAL IRREGULARITY; METRORRHAGIA; NAUSEA; PREGNANCY OUTCOME; PREGNANCY TEST; PRENATAL CARE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; SCREENING; SEXUALLY TRANSMITTED DISEASE; SKIN MANIFESTATION; SPOTTING; UNPLANNED PREGNANCY; UNSPECIFIED SIDE EFFECT; UTERUS PERFORATION; VAGINA DISEASE; WEIGHT GAIN; FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREVENTION AND CONTROL;

ADOLESCENT; CONFIDENTIALITY; CONTRACEPTION; COUNSELING; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN ADOLESCENCE;

EID: 84905913382     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2014.05.010     Document Type: Review

References (69)

1. Kost K., Henshaw S. U.S. teenage pregnancies, births and abortions, 2008: state trends by age, race and ethnicity 2013, Guttmacher Institute, New York.
2. Finer L.B., Henshaw S.K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006, 38(2):90-96.
3. Guttmacher Institute In brief: facts on induced abortion in the United States 2013, Guttmacher Institute, New York.
4. Martinez G., Copen C.E., Abma J.C. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. Vital Health Stat 23 2011, (31):1-35.
5. Santelli J.S., Lindberg L.D., Finer L.B., et al. Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health 2007, 97(1):150-156.
6. Eaton D.K., Kann L., Kinchen S., et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ 2012, 61(4):1-162.
7. Guttmacher Institute In brief: facts on publicly funded contraceptive services in the United States 2010, Guttmacher Institute, Washington, DC.
8. Gold R.B., Sonfield A., Richards C., et al. Next steps for America's family planning program: leveraging the potential of Medicaid and Title X in an evolving health care system 2009, Guttmacher Institute, New York.
9. Peipert J.F., Madden T., Allsworth J.E., et al. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 2012, 120(6):1291-1297.
10. Reddy D.M., Fleming R., Swain C. Effect of mandatory parental notification on adolescent girls' use of sexual health care services. JAMA 2002, 288(6):710-714.
11. Jones R.K., Purcell A., Singh S., et al. Adolescents' reports of parental knowledge of adolescents' use of sexual health services and their reactions to mandated parental notification for prescription contraception. JAMA 2005, 293(3):340-348.
12. Committee on Adolescence Counseling the adolescent about pregnancy options. Pediatrics 1998, 101(5):938-940.
13. Workowski K.A., Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010, 59(RR-12):1-110.
14. Dobkin L.M., Perrucci A.C., Dehlendorf C. Pregnancy options counseling for adolescents: overcoming barriers to care and preserving preference. Curr Probl Pediatr Adolesc Health Care 2013, 43(4):96-102.
15. Wolff T., Witkop C.T., Miller T., U.S.Preventive Services Task Force, et al. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 150(9):632-639.
16. Klein J.D. Adolescent pregnancy: current trends and issues. Pediatrics 2005, 116(1):281-286.
17. Raymond E.G., Grimes D.A. The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol 2012, 119(2 Pt 1):215-219.
18. Pinzon J.L., Jones V.F. Care of adolescent parents and their children. Pediatrics 2012, 130(6):e1743-e1756.
19. Elfenbein D.S., Felice M.E. Adolescent pregnancy. Pediatr Clin North Am 2003, 50(4):781-800. viii.
20. Aruda M.M., Waddicor K., Frese L., et al. Early pregnancy in adolescents: diagnosis, assessment, options counseling, and referral. JPediatr Health Care 2010, 24(1):4-13.
21. Ruedinger E., Cox J.E. Adolescent childbearing: consequences and interventions. Curr Opin Pediatr 2012, 24(4):446-452.
22. Grady M.A., Bloom K.C. Pregnancy outcomes of adolescents enrolled in a CenteringPregnancy program. JMidwifery Womens Health 2004, 49(5):412-420.
23. Irwin C.E., Adams S.H., Park M.J., et al. Preventive care for adolescents: few get visits and fewer get services. Pediatrics 2009, 123(4):e565-e572.
24. Guttmacher Institute Sex and America's teenagers 1994, Guttmacher Institute, New York.
25. Haffner D.W. Facing facts: sexual health for America's adolescents: the report of the National Commission on Adolescent Sexual Health. SIECUS Rep 1995, 23(6):2-8.
26. Oringanje C., Meremikwu M.M., Eko H., et al. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2009, (4). CD005215.
27. Kirby D. Emerging answers 2007: research findings on programs to reduce teen pregnancy and sexually transmitted diseases 2007, National Campaign to Prevent Teen and Unplanned Pregnancy, Washington, DC.
28. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2012, 120(4):983-988.
29. Mestad R., Secura G., Allsworth J.E., et al. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception 2011, 84(5):493-498.
30. O'Neil-Callahan M., Peipert J.F., Zhao Q., et al. Twenty-four-month continuation of reversible contraception. Obstet Gynecol 2013, 122(5):1083-1091.
31. Stoddard A., McNicholas C., Peipert J.F. Efficacy and safety of long-acting reversible contraception. Drugs 2011, 71(8):969-980.
32. Xu H., Wade J.A., Peipert J.F., et al. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol 2012, 120(1):21-26.
33. Palomba S., Falbo A., Di Cello A., et al. Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecol Endocrinol 2012, 28(9):710-721.
34. Peipert J.F., Zhao Q., Allsworth J.E., et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011, 117(5):1105-1113.
35. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC) U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep 2013, 62(RR-05):1-60.
36. Centers for Disease Control and Prevention (CDC) US medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep 2010, 59(RR-4):1-86.
37. Alton T.M., Brock G.N., Yang D., et al. Retrospective review of intrauterine device in adolescent and young women. JPediatr Adolesc Gynecol 2012, 25(3):195-200.
38. Hartman L.B., Monasterio E., Hwang L.Y. Adolescent contraception: review and guidance for pediatric clinicians. Curr Probl Pediatr Adolesc Health Care 2012, 42(9):221-263.
39. Hubacher D., Chen P.L., Park S. Side effects from the copper IUD: do they decrease over time?. Contraception 2009, 79(5):356-362.
40. Allen R.H., Bartz D., Grimes D.A., et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2009, (3). CD007373.
41. Hubacher D., Reyes V., Lillo S., et al. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006, 195(5):1272-1277.
42. Mody S.K., Kiley J., Rademaker A., et al. Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception 2012, 86(6):704-709.
43. McNicholas C., Peipert J.F. Long-acting reversible contraception for adolescents. Curr Opin Obstet Gynecol 2012, 24(5):293-298.
44. Waddington A., Reid R. More harm than good: the lack of evidence for administering misoprostol prior to IUD insertion. JObstet Gynaecol Can 2012, 34(12):1177-1179.
45. Espey E., Singh R.H., Leeman L., et al. Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial. Am J Obstet Gynecol 2014, 210(3):208.e1-208.e5.
46. Lathrop E., Haddad L., McWhorter C.P., et al. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception 2013, 88(6):725-729.
47. Ibrahim Z.M., Sayed Ahmed W.A. Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. Eur J Contracept Reprod Health Care 2013, 18(4):300-308.
48. Scavuzzi A., Souza A.S., Costa A.A., et al. Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Hum Reprod 2013, 28(8):2118-2125.
49. Winner B., Peipert J.F., Zhao Q., et al. Effectiveness of long-acting reversible contraception. NEngl J Med 2012, 366(21):1998-2007.
50. Paulen M.E., Curtis K.M. When can a woman have repeat progestogen-only injectables-depot medroxyprogesterone acetate or norethisterone enantate?. Contraception 2009, 80(4):391-408.
51. Bonny A.E., Secic M., Cromer B. Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate. Obstet Gynecol 2011, 117(4):793-797.
52. Isley M.M., Kaunitz A.M. Update on hormonal contraception and bone density. Rev Endocr Metab Disord 2011, 12(2):93-106.
53. Cullins V.E. Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate. JReprod Med 1996, 41(5 Suppl):428-433.
54. Halpern V., Lopez L.M., Grimes D.A., et al. Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database Syst Rev 2013, (10). CD004317.
55. Cromer B.A., Smith R.D., Blair J.M., et al. Aprospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics 1994, 94(5):687-694.
56. Abdel-Aleem H., d'Arcangues C., Vogelsong K.M., et al. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2013, (10). CD003449.
57. Carvajal D.N., Brittner M.R., Rubin S.E. Can apps reduce rates of teen pregnancy?. JFam Pract 2013, 62(10):538,598.
58. Raine T.R., Foster-Rosales A., Upadhyay U.D., et al. One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives. Obstet Gynecol 2011, 117(2 Pt 1):363-371.
59. Rubinstein M.L., Halpern-Felsher B.L., Irwin C.E. An evaluation of the use of the transdermal contraceptive patch in adolescents. JAdolesc Health 2004, 34(5):395-401.
60. Bodner K., Bodner-Adler B., Grunberger W. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users. Arch Gynecol Obstet 2011, 283(3):525-530.
61. Lara-Torre E., Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception 2002, 66(2):81-85.
62. Dinger J., Minh T.D., Buttmann N., et al. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol 2011, 117(1):33-40.
63. Grimes D.A., Lopez L.M., O'Brien P.A., et al. Progestin-only pills for contraception. Cochrane Database Syst Rev 2013, (11). CD007541.
64. Wu S., Godfrey E.M., Wojdyla D., et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010, 117(10):1205-1210.
65. Dalby J., Hayon R., Paddock E., et al. Emergency contraception: an underutilized resource. JFam Pract 2012, 61(7):392-397.
66. Glasier A.F., Cameron S.T., Fine P.M., et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010, 375(9714):555-562.
67. Glasier A., Cameron S.T., Blithe D., et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011, 84(4):363-367.
68. Committee on Adolescence Condom use by adolescents. Pediatrics 2013, 132:973-981.
69. Bearinger L.H., Resnick M.D. Dual method use in adolescents: a review and framework for research on use of STD and pregnancy protection. JAdolesc Health 2003, 32(5):340-349.